Common Immune Drug Methotrexate May Hamper Response to COVID-19 Vaccine
WEDNESDAY, May 26, 2021 -- A widely used medicine for autoimmune diseases may lower people ' s immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests.
The drug, called methotrexate, is often given to patients with immune-mediated...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Autoimmune Disease | COVID-19 | General Medicine | Methotrexate | Pfizer | Study | Vaccines